Animal Diagnostics Market - Databook 2025 to 2034

The global animal diagnostics market size was evaluated at USD 9.08 billion in 2024 and is expected to grow around USD 14.93 billion by 2034, registering a CAGR of 5.1% from 2025 to 2034.

Highlights of the Animal Diagnostics Market

• North America dominated the global market in 2024.
• Asia Pacific is anticipated to grow at the fastest rate in the market during the forecast period.
• By product type, the kits and reagents segment held a dominant presence in the market in 2024.
• By product type, the instruments segment is expected to grow at the fastest rate in the market during the forecast period of 2025 to 2034.
• By technology type, the molecular diagnostics segment accounted for a considerable share of the market in 2024.
• By technology type, the hematology segment is projected to experience the highest growth rate in the market between 2025 and 2034.
• By animal type, the companion animals segment led the animal diagnostics market.
• By animal type, the livestock animal segment is set to experience the fastest rate of market growth from 2025 to 2034.

Industry Valuation and Growth Rate Projection

The animal diagnostic market is where different diseases are detected, monitored, and managed for those animals whose basic health and existence need to be maintained. These comprise diagnostic technologies that, while at veterinary premises, would look at blood, tissue, urine, or feces for signs of disease or health markers. Ranging factors have contributed to the increase of the market, with concern about animal health and preventive care measures.

Enhancements in diagnostic technologies, such as molecular diagnostics, imaging systems, and point-of-care testing, have aided veterinary practitioners in early disease detection and intervening at the right time. Digital tools can detect a health pattern that could have been overlooked among many interferences during the traditional examination, hence enabling a more proactive and tailored veterinary practice. The aging pet population, increased governmental and private sector investments in animal welfare, urbanization, and pet ownership trends all contribute to the proliferation of veterinary diagnostic centers.

Animal Diagnostics Market: Stats and Figures

• Dogs are the most popular pet, with about 45% of US households owning them, followed closely by cats, which are kept by about 29% of households.
• Approximately 25% of American households own a cat, with an estimated 46.5 million households having at least one cat.
• An estimated 10 million animals die from abuse or cruelty every year in the United States.
• In 2025, the US has an estimated 57,125 veterinary services businesses, with the market projected to reach $121.79 billion.

How AI Has Benefitted the Market?

• Diagnosis With Higher Precision: AI can analyze histopathological images, detecting abnormalities and patterns that may be so subtle that they escape recognition by the human eye. This enhances precision in diagnoses.
• Consistent Interpretation: In doing so, AI limits bias and variability among pathologists and enhances analysis through standardized processes and criteria.
• Time-Saving and Faster Turnaround: AI handles all more mundane tasks, such as counting cells, measuring, or annotating the images, so that the turnaround time can be shortened and the workflow improved.
• Supports Difficult Cases: Pathologists will be able to concentrate on analyzing complex or peculiar cases, with AI tackling the routine ones. There is thus an improvement in the depth of the diagnosis.
• Rare Disease Telepathology: Remote consultations for diagnosis with a range of AI-assisted methods make expert pathology services accessible across geographic constraints.
• Research and Prediction Improvements: Through vast data merging and recognition of patterns, AI uncovers new biomarkers for the disease and supports the predictive modeling of treatments.

Industry Leader Announcements

• Jesper Söderqvist., CEO and Group President of Boule Diagnostics :

The rise in companion animals is driving the demand for veterinary diagnostics. This week, we launched the H50V solution, and we have already dispatched the first batch of instruments to our customers. The H50V, along with our existing Exigo H400 and Exigo C200 solutions, strengthens our veterinary portfolio. This, in combination with our expanded sales footprint through FujiFilm Europe, creates new opportunities for Boule to grow the veterinary business.

• Destina chief executive officer Hugh Ilyine:

“We are excited by the huge potential of this new company, which will apply Destina’s unique, patented technology for detecting nucleic acids by developing diagnostics tests for the animal health and veterinary arena, in combination with the animal health and commercialization expertise of Roslin Technologies.”

Geographical Insights

North America

North America is the leading country in animal diagnostics in 2024. Urbanization, increased disposable incomes, and higher rates of pet adoption led to this market's growth. Pet care and preventive diagnostics are special emphasis areas for the region.

Asia-Pacific

Asia-Pacific is expected to witness very aggressive growth owing to growing middle-class populations, urbanization, and pet ownership, especially in China and India. With increasing awareness of animal health and zoonotic disease risks, more investments are channelized toward veterinary diagnostics. Veterinary infrastructure improvements, with the expanding reach of diagnostic services, further provide impetus to market growth.

Europe

Europe is anticipated to grow at a moderate CAGR on account of strong regulatory support concerning animal welfare, widespread awareness about zoonotic diseases, and a fully developed ecosystem for veterinary care. Humanization of pets and government schemes are leading to the uptake of modern diagnostic solutions. With increasing demand for livestock diagnostics concerning food safety, the market is poised for further expansion across European nations.

Recent Developments:

• In May 2025, Zoetis, a leading global animal health services company, opened a diagnostics reference laboratory at the UPS Healthcare Labport in Louisville, attended by Gov. Andy Beshear and local officials. In March 202, Antech launched trūRapid™ FOUR, a comprehensive in-house test for canine vector-borne diseases, detecting antibodies to Anaplasma, Ehrlichia, Lyme C6, and heartworm using whole blood, serum, or plasma.

Competitive Landscape

The market is moderately fragmented with local players like IDEXX Laboratories, Inc., Embark Veterinary, Inc., Agrolabo S.p.A., Thermo Fisher Scientific, Inc., Esaote SPA, Innovative Diagnostics SAS, Zoetis, Antech Diagnostics, Inc. (Mars Inc.), Virbac, FUJIFILM Corporation, etc., wishing to take the time to edge their presence through investments, partnerships, acquisitions, and mergers. They also invest in product development and competitive pricing. These strategies will promote market growth and lucrative opportunities for market players

• Company Name: IDEXX Laboratories, Inc
• Year of Incorporation: 1983
• Headquarters: Westbrook, Maine

IDEXX Laboratories' revenue for the twelve months ending December 31, 2024, was $3.898B, a 6.46% increase year-over-year. IDEXX Laboratories' annual revenue for 2024 was $3.898B, a 6.46% increase from 2023.

• Company Name: Thermo Fisher Scientific, Inc.
• Year of Incorporation: 1956
• Headquarters: Waltham, Massachusetts, U.S

It ranked 97th on the Fortune 500 list based on its 2022 annual revenue of US$44.92 billion.

• Company Name: FUJIFILM Corporation
• Year of Incorporation: 1934
• Headquarters: Akasaka 9-chome, Minato-ku, Tokyo 107-0052, Japan.

According to Fujifilm's latest financial reports, the company's current revenue (TTM ) is ₹1.726 trillion. In 2023, the company made a revenue of ₹1.716 trillion, an increase over the revenue in the year 2022, that were of ₹1.715 trillion.